Skip to main content
SpringerLink
Log in

Is modified retroperitoneal lymph node dissection (MRLND) still feasible in the treatment of patients with clinical stage I non-seminomatous testicular cancer?

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

The results of treatment by means of modified RLND in 52 patients with clinical stage I non-seminomatous testicular cancer are presented. Retroperitoneal lymph node metastases were found in 15 patients (28.8%) with clinical stage I (CS-I) diagnosed prior to surgery. They received chemotherapy according to PVB schedule. Ejaculation disturbances persisted in 4 patients (7.7%). Relapses occurred in 4 patients (7.7%) from the group without lymph node metastases, and complete remission occurred after adjuvant PVB chemotherapy. All patients are still alive. Among the analysed factors which might favour development of metastases, only neoplastic invasion of the blood vessels of the primary tumour was statistically significant. In the authors’ opinion MRLND may still be used as a diagnostic and therapeutic method in clinical stage I non-seminomatous testicular cancer besides “watch policy” or primary chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aass, N., Fossa, S. D., Lien, H. H., Stenwig, E., Paus, E., Kaalhus, O.: Is routine primary retroperitoneal lymph node dissection still justified in patients with low node stage non-seminomatous testicular cancer?Br. J. Urol. 65, 385 (1990).

    Article  PubMed  CAS  Google Scholar 

  2. Foster, R. S., Donohue, J. P., Bihrle, R.: Stage A nonseminomatous testis carcinoma: rationale and results of nerve-sparing retroperitoneal lymphadenectomy.Urol. Int., 46, 294 (1991).

    Article  PubMed  CAS  Google Scholar 

  3. Frang, D., Farkas, L., Götz, F., Székely, J. Jr.: Prognosis of testicular tumour since the introduction of complex therapy.Int. Urol. Nephrol. 21, 1 (1989).

    Article  Google Scholar 

  4. Hoeltl, W., Pont, J., Kosak, D., Honetz, N., Marberger, M.: Treatment decision of stage I non-seminomatous germ cell tumours based on the risk factor “vascular invasion”.Br. J. Urol., 69, 83 (1992).

    PubMed  CAS  Google Scholar 

  5. Horwich, A., Peckham, M. J.: Surveillance after orchidectomy for clinical stage I germ-cell tumors of the testis. EORTC Genitourinary Group Monograph 5: Progress and Controversies in Oncological Urology. Alan R. Liss Inc., New York 1988, p. 471.

    Google Scholar 

  6. Klepp, O., Olsson, A. M., Ous, S., Nilsson, S., Hoisaether, P. A., Tveter, K.: Early clinical stage of nonseminomatous testis cancer.Scand. J. Urol. Nephrol. 25, 179 (1991).

    PubMed  CAS  Google Scholar 

  7. Kułakowski, A., Dardziński, R.: Retroperitoneal lymph node dissection in the treatment of patients with non-seminoma testicular tumors.Eur. J. Surg. Oncol., 17, 581 (1991).

    PubMed  Google Scholar 

  8. Madej, G., Pawiński, A.: Risk-related adjuvant chemotherapy for stage I non-seminoma of the testis.Clin. Oncol. R-Coll-Radiol. 3, 170 (1991).

    Google Scholar 

  9. Oliver, R. T. D., Dhalival, H. S., Hope-Stone, H. F., Blandy, J. P.: Short course etoposide, bleomycin and cisplatin in the treatment of metastatic germ cell tumors. Appraisal of its potential as adjuvant chemotherapy for stage I testis tumors.Br. J. Urol., 15, 324 (1988).

    Google Scholar 

  10. Pizzocaro, G., Zanoni, F., Salvioni, R., Milani, A., Piva, L., Pilotti, S.: Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I non-seminomatous germ cell tumors of the testis.J. Urol., 138, 1393 (1987).

    PubMed  CAS  Google Scholar 

  11. Pizzocaro, G., Nicolai, N., Salvioni, R., Piva, L., Faustini, M., Zanoni, M., Milani, A.: Comparison between clinical and pathological staging in low stage nonseminomatous germ cell testicular tumors.J. Urol., 148, 76 (1992).

    PubMed  CAS  Google Scholar 

  12. Raghavan, D., Colls, B., Levi, J., Fitzharris, B., Tattersall, M. H. N., Atkinson, C., Woods, R., Coorey, G., Farrel, C., Wines, R.: Surveillance for stage I non-seminomatous germ cell tumors of the testis: the optimal protocol has not yet been defined.Br. J. Urol., 61, 552 (1988).

    Google Scholar 

  13. Richie, J. P.: Clinical stage I testicular cancer: the role of modified retroperitoneal lymphadenectomy.J. Urol., 144, 1160 (1990).

    PubMed  CAS  Google Scholar 

  14. Rorth, M.: Therapeutic alternatives in clinical stage I nonseminomatous disease.Sem. Oncol., 19, 190 (1992).

    CAS  Google Scholar 

  15. Roth, B. J., Wiliams, S. D.: Complications of urologic chemotherapy.AUA Update Series, 9, 26 (1990).

    Google Scholar 

  16. Sogani, C. P.: Evolution of the management of stage I nonseminomatous germ-cell tumors of the testis.Urol. Clin. North Amer., 18, 561 (1991).

    CAS  Google Scholar 

  17. Sosnowski, M., Jeromin, L., Płużańska, A.: Application of modified retroperitoneal lymph node dissection (MRLND) in the treatment of patients with stage I nonseminomatous testicular tumors (in Polish).Nowotwory, 42, 156 (1992).

    Google Scholar 

  18. Weissbach, L., Boedefeld, E. A., Horstman-Dubral, B.: Surgical treatment of stage I non-seminomatous germ cell testis tumor. Final results of a prospective multicenter trial 1982–1987.Eur. Urol., 17, 97 (1990).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Medical University of Łódż, Łódż, Poland

    M. Sosnowski, L. Jeromin & A. Płużanska

  2. Department of Chemotherapy, Regional Oncological Centre, Łódż, Poland

    M. Sosnowski, L. Jeromin & A. Płużanska

Authors
  1. M. Sosnowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Jeromin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Płużanska
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sosnowski, M., Jeromin, L. & Płużanska, A. Is modified retroperitoneal lymph node dissection (MRLND) still feasible in the treatment of patients with clinical stage I non-seminomatous testicular cancer?. International Urology and Nephrology 26, 471–477 (1994). https://doi.org/10.1007/BF02768020

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02768020

Keywords

Search

Navigation